+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Forecast 2023-2030- Product Image
Global Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Forecast 2023-2030- Product Image
Sale

Global Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Forecast 2023-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4985960
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Self-injections Market size was estimated at USD 48.14 billion in 2022, USD 54.00 billion in 2023, and is expected to grow at a CAGR of 12.65% to reach USD 124.87 billion by 2030.

Self-injections refer to the products used to administer medication to themselves intramuscularly, subcutaneously, or intravenously without the immediate assistance of healthcare professionals. Self-injections are used for treatments that require regular and long-term care, such as insulin for diabetes, hormones for hormone replacement therapy and fertility treatments, and biologics for chronic conditions. Self-injection devices are widely used to increase autonomy and can improve treatment adherence by eliminating the need for healthcare provider administration. An elevating prevalence of chronic diseases, the need for home-based healthcare, advancements in drug delivery technology, and a growing patient preference for self-administration have improved the usage of self-injections in recent years. However, the requirement for significant investment in research and development, patient safety and comfort concerns, and the need for cold chain storage and logistics for biologics limit the product penetration of self-injections. Recognition of digitization and patient-centricity leads to opportunities for integrating smart technology into self-injection devices. Innovations focusing on connectivity can provide data collection, patient monitoring, and adherence tracking, guiding personalized treatment modalities for self-injections. Moreover, the supportive government approvals for self-injections are further expanding the scope of the market.

Regional Insights

The self-injections market in the Americas is driven by a strong emphasis on patient-centric care, advanced healthcare infrastructure, and an increase in biologic drug approvals that require patient-friendly administration. Consumers are becoming increasingly aware of self-care options, including self-injection devices, which align with convenience. Government initiatives to reduce hospital stays and promote self-administration of medication also contribute to the penetration of self-injections in the Americas. In the European Union, market growth for self-injection devices is supported by an aging population, the prevalence of chronic diseases, and a strong inclination toward self-management of these conditions. The EU's rigorous regulatory framework ensures high safety standards for self-injection devices. Furthermore, several EU countries have been active in running patient education programs to encourage the adoption of self-injection practices. In the Middle East and Africa, substantial investments in healthcare infrastructure and an increasing incidence of lifestyle-related diseases show promising growth for the self-injections market. In the Asia-Pacific region, rapid economic growth and increased healthcare expenditure are major drivers for the self-injections market. The government's emphasis on pharmaceutical innovation and the surging prevalence of chronic diseases are boosting demand. Furthermore, a technologically advanced healthcare system and an aging population enable the market for self-injection devices in the Asia Pacific.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Self-injections Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Self-injections Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Self-injections Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Antares Pharma, Inc. by Halozyme, Inc., AstraZeneca plc, Baxter International, Inc., Becton, Dickinson and Company, Credence MedSystems, Inc., DALI Medical Devices Ltd., Eli Lilly and Company, Enable Injections, Inc., Gerresheimer AG, GlaxoSmithKline plc, Insulet Corporation, Johnson & Johnson Services, Inc., Medmix AG by Sulzer Ltd., Merck KGaA, Molex LLC by Koch Industries, Inc., Mylan N.V. by Viatris Inc., Novo Nordisk A/S, Owen Mumford Limited, PenJet Corporation, Pfizer Inc., PharmaJet, Inc., Recipharm AB, Sanofi S.A., SCHOTT AG, SHL Medical AG, Terumo Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed Group.

Market Segmentation & Coverage

This research report categorizes the Self-injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Auto-Injectors
    • Needle-free Injectors
    • Pen Injectors
    • Wearable Injectors
  • Usage
    • Disposable
    • Reusable
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Private Clinics
  • Therapeutic Areas Application
    • Autoimmune Diseases
      • AIDS
      • Allergies
      • Cancer
      • Irritable Bowel Disorders
      • Multiple Sclerosis
      • Psoriasis
    • Emergency Drugs
      • Anaphylactic Socks
      • Migraine
    • Hormone Replacement Therapies
      • Beta-Interferon
      • Erythropoietin
      • Follicle Stimulating Hormone
      • Heparin
      • Insulin
      • Parathyroid Hormone
      • Parkinson’s
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Self-injections Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Self-injections Market?
  3. What are the technology trends and regulatory frameworks in the Self-injections Market?
  4. What is the market share of the leading vendors in the Self-injections Market?
  5. Which modes and strategic moves are suitable for entering the Self-injections Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Self-injections Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid prevalence of chronic diseases and rheumatoid arthritis
5.1.1.2. Wide availability of self-injections for fertility treatments
5.1.2. Restraints
5.1.2.1. Potential risk of product recall
5.1.3. Opportunities
5.1.3.1. Ongoing government approvals for self-injections worldwide
5.1.3.2. Technological advancements in self-injection devices
5.1.4. Challenges
5.1.4.1. Limited awareness and administration challenges associated with self-injections
5.2. Market Segmentation Analysis
5.2.1. Type: Rising preference for pen injectors to manage chronic diseases
5.2.2. Usage: Growing use of disposable self-injections to avoid the risk of cross-contamination
5.2.3. Distribution Channel: Emerging penetration of self-injections on online platforms
5.2.4. Therapeutic Areas Application: Growing applications of self-injections to treat hormonal issues
5.3. Market Trend Analysis
5.3.1. Rising incidents of diabetes and chronic diseases creating need for self-injections in the Americas
5.3.2. Growing investment in healthcare infrastructure and innovation in self-injections devices in APAC region
5.3.3. Supportive government approvals for self-injections in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Self-injections Market, by Type
6.1. Introduction
6.2. Auto-Injectors
6.3. Needle-free Injectors
6.4. Pen Injectors
6.5. Wearable Injectors
7. Self-injections Market, by Usage
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Self-injections Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Private Clinics
9. Self-injections Market, by Therapeutic Areas Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3.1. AIDS
9.3.2. Allergies
9.3.3. Cancer
9.3.4. Irritable Bowel Disorders
9.3.5. Multiple Sclerosis
9.3.6. Psoriasis
9.3. Emergency Drugs
9.4.1. Anaphylactic Socks
9.4.2. Migraine
9.4. Hormone Replacement Therapies
9.5.1. Beta-Interferon
9.5.2. Erythropoietin
9.5.3. Follicle Stimulating Hormone
9.5.4. Heparin
9.5.5. Insulin
9.5.6. Parathyroid Hormone
9.5.7. Parkinson’s
10. Americas Self-injections Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Self-injections Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Self-injections Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Eitan Medical Completes Transition of Wearable Injectors Business
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Civica Partners With Ypsomed For Insulin Injection Pen
13.3.2.2. Ypsomed Enhances Self-Injection Device Platforms With Integrated Human Factors Services
13.3.2.3. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
13.3.3. New Product Launch & Enhancement
13.3.3.1. Altaviz introduces New Auto-Injector Platform For Drug Delivery
13.3.3.2. Coherus Announces U.S. Launch of UDENYCA Autoinjector
13.3.3.3. Phillips-Medisize Expands Product Portfolio with Launch of a Pen Injector Platform Designed to Lower Pharma Costs, Risks and Market Barriers
13.3.4. Investment & Funding
13.3.4.1. Micron Biomedical Receives Funds To Produce Needle-Free Vaccines
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
13.3.5.2. FDA Approves On-Body Injector for Self Administration of Pegcetacoplan for PNH
13.3.5.3. US FDA Approves Tezspire For Self-Administration Using Pre-Filled Pen
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AbbVie Inc.
14.1.2. Antares Pharma, Inc. by Halozyme, Inc.
14.1.3. AstraZeneca plc
14.1.4. Baxter International, Inc.
14.1.5. Becton, Dickinson and Company
14.1.6. Credence MedSystems, Inc.
14.1.7. DALI Medical Devices Ltd.
14.1.8. Eli Lilly and Company
14.1.9. Enable Injections, Inc.
14.1.10. Gerresheimer AG
14.1.11. GlaxoSmithKline plc
14.1.12. Insulet Corporation
14.1.13. Johnson & Johnson Services, Inc.
14.1.14. Medmix AG by Sulzer Ltd.
14.1.15. Merck KGaA
14.1.16. Molex LLC by Koch Industries, Inc.
14.1.17. Mylan N.V. by Viatris Inc.
14.1.18. Novo Nordisk A/S
14.1.19. Owen Mumford Limited
14.1.20. PenJet Corporation
14.1.21. Pfizer Inc.
14.1.22. PharmaJet, Inc.
14.1.23. Recipharm AB
14.1.24. Sanofi S.A.
14.1.25. SCHOTT AG
14.1.26. SHL Medical AG
14.1.27. Terumo Corporation
14.1.28. Teva Pharmaceutical Industries Ltd.
14.1.29. West Pharmaceutical Services, Inc.
14.1.30. Ypsomed Group
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. SELF-INJECTIONS MARKET RESEARCH PROCESS
FIGURE 2. SELF-INJECTIONS MARKET SIZE, 2022 VS 2030
FIGURE 3. SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SELF-INJECTIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. SELF-INJECTIONS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. SELF-INJECTIONS MARKET DYNAMICS
FIGURE 7. SELF-INJECTIONS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. SELF-INJECTIONS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. SELF-INJECTIONS MARKET SIZE, BY USAGE, 2022 VS 2030 (%)
FIGURE 10. SELF-INJECTIONS MARKET SIZE, BY USAGE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 12. SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2022 VS 2030 (%)
FIGURE 14. SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. SELF-INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 11. SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 20. SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 28. SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 32. SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. SELF-INJECTIONS MARKET SIZE, BY PARKINSON’S, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 61. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 63. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. CANADA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 66. CANADA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 67. CANADA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. MEXICO SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 73. MEXICO SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 98. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 100. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. CHINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. CHINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 103. CHINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 104. CHINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 105. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 107. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. INDIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. INDIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 110. INDIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 111. INDIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 119. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 121. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. JAPAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. JAPAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 124. JAPAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 125. JAPAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 161. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 163. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. THAILAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. THAILAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 166. THAILAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 167. THAILAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 183. DENMARK SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. DENMARK SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 185. DENMARK SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. DENMARK SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. DENMARK SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 188. DENMARK SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 189. DENMARK SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 190. EGYPT SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. EGYPT SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 192. EGYPT SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. EGYPT SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. EGYPT SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 195. EGYPT SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 197. FINLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. FINLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 199. FINLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. FINLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. FINLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 202. FINLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 203. FINLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 204. FRANCE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 206. FRANCE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. FRANCE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. FRANCE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 209. FRANCE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 211. GERMANY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. GERMANY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 213. GERMANY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. GERMANY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. GERMANY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 216. GERMANY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 217. GERMANY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 225. ITALY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. ITALY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 227. ITALY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. ITALY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. ITALY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 230. ITALY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 231. ITALY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 246. NORWAY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. NORWAY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 248. NORWAY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. NORWAY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. NORWAY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 251. NORWAY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 252. NORWAY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 253. POLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. POLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 255. POLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. POLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. POLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 258. POLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 259. POLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 260. QATAR SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. QATAR SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 262. QATAR SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. QATAR SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. QATAR SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 265. QATAR SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 266. QATAR SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 288. SPAIN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 290. SPAIN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. SPAIN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SPAIN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 293. SPAIN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 294. SPAIN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 309. TURKEY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 310. TURKEY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 311. TURKEY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. TURKEY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. TURKEY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 314. TURKEY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 315. TURKEY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
TABLE 330. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 331. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 332. SELF-INJECTIONS MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Antares Pharma, Inc. by Halozyme, Inc.
  • AstraZeneca plc
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Credence MedSystems, Inc.
  • DALI Medical Devices Ltd.
  • Eli Lilly and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medmix AG by Sulzer Ltd.
  • Merck KGaA
  • Molex LLC by Koch Industries, Inc.
  • Mylan N.V. by Viatris Inc.
  • Novo Nordisk A/S
  • Owen Mumford Limited
  • PenJet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • Sanofi S.A.
  • SCHOTT AG
  • SHL Medical AG
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Ypsomed Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 54 Billion
Forecasted Market Value ( USD ) by 2030 $ 124.87 Billion
Compound Annual Growth Rate12.6%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Global Self-injection Device Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Self-injection Device Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 153 Pages
  • Global
From
Self-Injections Global Market Report 2024 - Product Image

Self-Injections Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Injection Pen Market: Analysis By Type, By Therapy, By End User, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028 - Product Image

Global Injection Pen Market: Analysis By Type, By Therapy, By End User, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028

  • Report
  • 164 Pages
  • Global
From
Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2023-2030 - Product Image

Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2023-2030

  • Report
  • 197 Pages
  • Global
From
Global Pen Needles Market by Product (Safety Pen Needles, Standard Pen Needles), Length (10mm, 12mm, 4mm), Application, Mode of Purchase, Sales Channel, End-Use - Forecast 2023-2030 - Product Image

Global Pen Needles Market by Product (Safety Pen Needles, Standard Pen Needles), Length (10mm, 12mm, 4mm), Application, Mode of Purchase, Sales Channel, End-Use - Forecast 2023-2030

  • Report
  • 185 Pages
  • Global
From

About the Self Injectable Device Market

The Self Injectable Device market is a subset of the Home Testing and Home Healthcare industry. It includes products such as auto-injectors, pre-filled syringes, and pen injectors, which are used to deliver medications to patients in their own homes. These devices are designed to be easy to use and provide accurate dosing, allowing patients to self-administer their medications without the need for a healthcare professional. Self Injectable Devices are becoming increasingly popular due to their convenience and cost-effectiveness. The Self Injectable Device market is highly competitive, with a number of companies offering products for a variety of medical conditions. Some of the major players in the market include Becton Dickinson, Novo Nordisk, Sanofi, Eli Lilly, and Pfizer. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.